Steglatro
Generic name: Ertugliflozin
Drug class:
SGLT-2 inhibitors
Usage of Steglatro
Steglatro is an oral diabetes medicine that helps control blood sugar levels. Ertugliflozin works by helping the kidneys get rid of glucose from your bloodstream.
Steglatro is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Steglatro is not for treating type 1 diabetes.
Steglatro side effects
Get emergency medical help if you have signs of an allergic reaction to Steglatro: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Seek medical attention right away if you have signs of a genital infection (penis or vagina): burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, not feeling well. These symptoms may get worse quickly.
Call your doctor at once if you have:
Some side effects may be more likely to occur in older adults.
Common Steglatro side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Steglatro
You should not use Steglatro if you are allergic to ertugliflozin, or if you have:
Steglatro may increase your risk of lower leg amputation, especially if you have had a prior amputation, a foot ulcer, heart disease, circulation problems, or nerve damage.
To make sure Steglatro is safe for you, tell your doctor if you have ever had:
Follow your doctor's instructions about using Steglatro if you are pregnant. Blood sugar control is very important during pregnancy, and your dose needs may be different during each trimester.
You should not use ertugliflozin during the second or third trimester of pregnancy.
You should not breast-feed while using this medicine.
Steglatro is not approved for use by anyone younger than 18 years old.
Relate drugs
- Bexagliflozin
- Brenzavvy
- Canagliflozin
- Dapagliflozin
- Empagliflozin
- Ertugliflozin
- Farxiga
- Invokana
- Jardiance
- Steglatro
How to use Steglatro
Usual Adult Dose for Diabetes Type 2:
Initial dose: 5 mg orally once a day in the morning -May increase to 15 mg orally once a day for patients tolerating therapy and requiring additional glycemic control Maximum dose: 15 mg per day Comments: -Volume depletion should be corrected prior to initiating therapy. -This drug is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Use: An adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
Warnings
You should not use Steglatro if you have severe kidney disease or if you are on dialysis.
Ertugliflozin may increase your risk of lower leg amputation, especially if you have had a prior amputation, a foot ulcer, heart disease, circulation problems, or nerve damage.
Steglatro can cause serious infections in the penis or vagina. Get medical help right away if you have burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, or if you don't feel well.
What other drugs will affect Steglatro
When you start or stop taking Steglatro, your doctor may need to adjust the doses of any other diabetes medicines you use on a regular basis.
Other drugs may interact with ertugliflozin, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions